{
    "medicine_id": "55f6a55b491c7737b09ed1cc88f0de908e1b5f98",
    "platform_id": "DB01204",
    "metadata": {
        "name": "Mitoxantrone 2 mg 1mL Injection solution",
        "composition": "2 mg 1mL Mitoxantrone",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment of secondary chronic progressive progressive relapsing or worsening relapsing remitting multiple sclerosis",
            "contraindications": {
                "disease": "Severe leukopenia with infection",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Mitoxantrone has been shown in vitro to inhibit B cell T cell and macrophage proliferation and impair antigen presentation as well as the secretion of interferon gamma TNFa and IL 2",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB06643",
                        "description": "The risk or severity of adverse effects can be increased when Denosumab is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00005",
                        "description": "The risk or severity of adverse effects can be increased when Etanercept is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00008",
                        "description": "The risk or severity of adverse effects can be increased when Peginterferon alfa 2a is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00011",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa n1 is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00018",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa n3 is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "The risk or severity of adverse effects can be increased when Peginterferon alfa 2b is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00026",
                        "description": "The risk or severity of adverse effects can be increased when Anakinra is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00033",
                        "description": "The risk or severity of adverse effects can be increased when Interferon gamma 1b is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00034",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa 2a Recombinant is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "The risk or severity of adverse effects can be increased when Aldesleukin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "The risk or severity of adverse effects can be increased when Adalimumab is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00056",
                        "description": "The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00059",
                        "description": "The risk or severity of adverse effects can be increased when Pegaspargase is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The risk or severity of adverse effects can be increased when Infliximab is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00068",
                        "description": "The risk or severity of adverse effects can be increased when Interferon beta 1b is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00069",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfacon 1 is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00073",
                        "description": "The risk or severity of adverse effects can be increased when Rituximab is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00074",
                        "description": "The risk or severity of adverse effects can be increased when Basiliximab is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00075",
                        "description": "The risk or severity of adverse effects can be increased when Muromonab is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00078",
                        "description": "The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00081",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00087",
                        "description": "The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00092",
                        "description": "The risk or severity of adverse effects can be increased when Alefacept is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00095",
                        "description": "The risk or severity of adverse effects can be increased when Efalizumab is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00098",
                        "description": "The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin rabbit is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00105",
                        "description": "The risk or severity of adverse effects can be increased when Interferon alfa 2b is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00111",
                        "description": "The risk or severity of adverse effects can be increased when Daclizumab is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00112",
                        "description": "The risk or severity of adverse effects can be increased when Bevacizumab is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00120",
                        "description": "The risk or severity of adverse effects can be increased when Phenylalanine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00180",
                        "description": "The risk or severity of adverse effects can be increased when Flunisolide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00242",
                        "description": "The risk or severity of adverse effects can be increased when Cladribine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00262",
                        "description": "The risk or severity of adverse effects can be increased when Carmustine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00276",
                        "description": "The risk or severity of adverse effects can be increased when Amsacrine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00290",
                        "description": "The risk or severity of adverse effects can be increased when Bleomycin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00291",
                        "description": "The risk or severity of adverse effects can be increased when Chlorambucil is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00293",
                        "description": "The risk or severity of adverse effects can be increased when Raltitrexed is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00305",
                        "description": "The risk or severity of adverse effects can be increased when Mitomycin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00307",
                        "description": "The risk or severity of adverse effects can be increased when Bexarotene is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00322",
                        "description": "The risk or severity of adverse effects can be increased when Floxuridine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "The risk or severity of adverse effects can be increased when Indomethacin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00352",
                        "description": "The risk or severity of adverse effects can be increased when Tioguanine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00380",
                        "description": "The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00394",
                        "description": "The risk or severity of adverse effects can be increased when Beclomethasone dipropionate is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00428",
                        "description": "The risk or severity of adverse effects can be increased when Streptozocin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00432",
                        "description": "The risk or severity of adverse effects can be increased when Trifluridine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "The risk or severity of adverse effects can be increased when Gemcitabine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The risk or severity of adverse effects can be increased when Betamethasone is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00445",
                        "description": "The risk or severity of adverse effects can be increased when Epirubicin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00446",
                        "description": "The risk or severity of adverse effects can be increased when Chloramphenicol is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00480",
                        "description": "The risk or severity of adverse effects can be increased when Lenalidomide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00488",
                        "description": "The risk or severity of adverse effects can be increased when Altretamine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "The risk or severity of adverse effects can be increased when Zidovudine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "The risk or severity of adverse effects can be increased when Cisplatin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The risk or severity of adverse effects can be increased when Fluorouracil is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00550",
                        "description": "The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00552",
                        "description": "The risk or severity of adverse effects can be increased when Pentostatin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "The risk or severity of adverse effects can be increased when Fluticasone propionate is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00591",
                        "description": "The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "The risk or severity of adverse effects can be increased when Linezolid is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The risk or severity of adverse effects can be increased when Triamcinolone is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "The risk or severity of adverse effects can be increased when Clofarabine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "The risk or severity of adverse effects can be increased when Prednisone is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "The risk or severity of adverse effects can be increased when Pemetrexed is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00687",
                        "description": "The risk or severity of adverse effects can be increased when Fludrocortisone is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "The risk or severity of adverse effects can be increased when Mycophenolate mofetil is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "The risk or severity of adverse effects can be increased when Tretinoin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "The risk or severity of adverse effects can be increased when Methimazole is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00851",
                        "description": "The risk or severity of adverse effects can be increased when Dacarbazine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00853",
                        "description": "The risk or severity of adverse effects can be increased when Temozolomide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00859",
                        "description": "The risk or severity of adverse effects can be increased when Penicillamine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00860",
                        "description": "The risk or severity of adverse effects can be increased when Prednisolone is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00888",
                        "description": "The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00928",
                        "description": "The risk or severity of adverse effects can be increased when Azacitidine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00958",
                        "description": "The risk or severity of adverse effects can be increased when Carboplatin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00959",
                        "description": "The risk or severity of adverse effects can be increased when Methylprednisolone is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00970",
                        "description": "The risk or severity of adverse effects can be increased when Dactinomycin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00993",
                        "description": "The risk or severity of adverse effects can be increased when Azathioprine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01005",
                        "description": "The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01024",
                        "description": "The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01033",
                        "description": "The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "The risk or severity of adverse effects can be increased when Thalidomide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01042",
                        "description": "The risk or severity of adverse effects can be increased when Melphalan is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01073",
                        "description": "The risk or severity of adverse effects can be increased when Fludarabine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01099",
                        "description": "The risk or severity of adverse effects can be increased when Flucytosine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "The risk or severity of adverse effects can be increased when Capecitabine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of adverse effects can be increased when Procarbazine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The risk or severity of adverse effects can be increased when Idarubicin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01196",
                        "description": "The risk or severity of adverse effects can be increased when Estramustine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01206",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Lomustine"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Dexamethasone"
                    },
                    {
                        "drugbank-id": "DB01257",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Eculizumab"
                    },
                    {
                        "drugbank-id": "DB01262",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Decitabine"
                    },
                    {
                        "drugbank-id": "DB01280",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Nelarabine"
                    },
                    {
                        "drugbank-id": "DB01281",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Abatacept"
                    },
                    {
                        "drugbank-id": "DB01285",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Corticotropin"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Cortisone acetate"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Paramethasone"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Ciclesonide"
                    },
                    {
                        "drugbank-id": "DB01423",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Stepronin"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Hydroxychloroquine"
                    },
                    {
                        "drugbank-id": "DB01816",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Castanospermine"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Vorinostat"
                    },
                    {
                        "drugbank-id": "DB02806",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with 2 Methoxyethanol"
                    },
                    {
                        "drugbank-id": "DB03523",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Brequinar"
                    },
                    {
                        "drugbank-id": "DB04630",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Aldosterone"
                    },
                    {
                        "drugbank-id": "DB04951",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Pirfenidone"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Afelimomab"
                    },
                    {
                        "drugbank-id": "DB05258",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Interferon alfa"
                    },
                    {
                        "drugbank-id": "DB05259",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Glatiramer"
                    },
                    {
                        "drugbank-id": "DB05260",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Gallium nitrate"
                    },
                    {
                        "drugbank-id": "DB05459",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Briakinumab"
                    },
                    {
                        "drugbank-id": "DB05472",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Human interferon omega 1"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Apremilast"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Canakinumab"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Tocilizumab"
                    },
                    {
                        "drugbank-id": "DB06372",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Rilonacept"
                    },
                    {
                        "drugbank-id": "DB06612",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Mepolizumab"
                    },
                    {
                        "drugbank-id": "DB06662",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Abetimus"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Golimumab"
                    },
                    {
                        "drugbank-id": "DB06681",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Belatacept"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Bendamustine"
                    },
                    {
                        "drugbank-id": "DB06813",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Pralatrexate"
                    },
                    {
                        "drugbank-id": "DB08059",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Wortmannin"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Eribulin"
                    },
                    {
                        "drugbank-id": "DB08879",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Belimumab"
                    },
                    {
                        "drugbank-id": "DB08880",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Teriflunomide"
                    },
                    {
                        "drugbank-id": "DB08889",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Carfilzomib"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB08906",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Fluticasone furoate"
                    },
                    {
                        "drugbank-id": "DB08908",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Dimethyl fumarate"
                    },
                    {
                        "drugbank-id": "DB08935",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Obinutuzumab"
                    },
                    {
                        "drugbank-id": "DB08970",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Fluprednidene"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Secukinumab"
                    },
                    {
                        "drugbank-id": "DB09033",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Vedolizumab"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Siltuximab"
                    },
                    {
                        "drugbank-id": "DB09052",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Blinatumomab"
                    },
                    {
                        "drugbank-id": "DB09077",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Dinutuximab"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Vilanterol"
                    },
                    {
                        "drugbank-id": "DB09091",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Tixocortol"
                    },
                    {
                        "drugbank-id": "DB09122",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Peginterferon beta 1a"
                    },
                    {
                        "drugbank-id": "DB09312",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Antilymphocyte immunoglobulin horse"
                    },
                    {
                        "drugbank-id": "DB09378",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Fluprednisolone"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Meprednisone"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Tepoxalin"
                    },
                    {
                        "drugbank-id": "DB11487",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Dexamethasone isonicotinate"
                    },
                    {
                        "drugbank-id": "DB11529",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Melengestrol"
                    },
                    {
                        "drugbank-id": "DB11569",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Ixekizumab"
                    },
                    {
                        "drugbank-id": "DB11580",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Ravulizumab"
                    },
                    {
                        "drugbank-id": "DB11616",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Pirarubicin"
                    },
                    {
                        "drugbank-id": "DB11693",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Voclosporin"
                    },
                    {
                        "drugbank-id": "DB11708",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Peficitinib"
                    },
                    {
                        "drugbank-id": "DB11767",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Sarilumab"
                    },
                    {
                        "drugbank-id": "DB11776",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Brodalumab"
                    },
                    {
                        "drugbank-id": "DB11803",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Sirukumab"
                    },
                    {
                        "drugbank-id": "DB11834",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Guselkumab"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Deflazacort"
                    },
                    {
                        "drugbank-id": "DB12025",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Triptolide"
                    },
                    {
                        "drugbank-id": "DB12612",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Ozanimod"
                    },
                    {
                        "drugbank-id": "DB12617",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Mizoribine"
                    },
                    {
                        "drugbank-id": "DB12692",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Gusperimus"
                    },
                    {
                        "drugbank-id": "DB12814",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Cepeginterferon alfa 2B"
                    },
                    {
                        "drugbank-id": "DB12902",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Trofosfamide"
                    },
                    {
                        "drugbank-id": "DB12947",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Doxifluridine"
                    },
                    {
                        "drugbank-id": "DB12991",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Deoxyspergualin"
                    },
                    {
                        "drugbank-id": "DB12996",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Acteoside"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Cortivazol"
                    },
                    {
                        "drugbank-id": "DB13014",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Hypericin"
                    },
                    {
                        "drugbank-id": "DB13068",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with 9 N methyl L isoleucine cyclosporin A"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Prednylidene"
                    },
                    {
                        "drugbank-id": "DB13223",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Fluocortin"
                    },
                    {
                        "drugbank-id": "DB13241",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Begelomab"
                    },
                    {
                        "drugbank-id": "DB13491",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Fluperolone"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Cloprednol"
                    },
                    {
                        "drugbank-id": "DB13856",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Fluclorolone"
                    },
                    {
                        "drugbank-id": "DB13867",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Fluticasone"
                    },
                    {
                        "drugbank-id": "DB14066",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Tetrandrine"
                    },
                    {
                        "drugbank-id": "DB14219",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Monomethyl fumarate"
                    },
                    {
                        "drugbank-id": "DB14512",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Mometasone furoate"
                    },
                    {
                        "drugbank-id": "DB14539",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Hydrocortisone acetate"
                    },
                    {
                        "drugbank-id": "DB14545",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Hydrocortisone succinate"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Emapalumab"
                    },
                    {
                        "drugbank-id": "DB14762",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Risankizumab"
                    },
                    {
                        "drugbank-id": "DB14919",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Rozanolixizumab"
                    },
                    {
                        "drugbank-id": "DB15253",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Bleselumab"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "The risk or severity of adverse effects can be increased when Topotecan is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Budesonide"
                    },
                    {
                        "drugbank-id": "DB00694",
                        "description": "The risk or severity of adverse effects can be increased when Daunorubicin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00987",
                        "description": "The risk or severity of adverse effects can be increased when Cytarabine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01108",
                        "description": "The risk or severity of adverse effects can be increased when Trilostane is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB05015",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Belinostat"
                    },
                    {
                        "drugbank-id": "DB01013",
                        "description": "The risk or severity of adverse effects can be increased when Clobetasol propionate is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01047",
                        "description": "The risk or severity of adverse effects can be increased when Fluocinonide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB14540",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Hydrocortisone butyrate"
                    },
                    {
                        "drugbank-id": "DB00547",
                        "description": "The risk or severity of adverse effects can be increased when Desoximetasone is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00764",
                        "description": "The risk or severity of adverse effects can be increased when Mometasone is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB08971",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Fluocortolone"
                    },
                    {
                        "drugbank-id": "DB11750",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Clobetasol"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The risk or severity of adverse effects can be increased when Imatinib is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00324",
                        "description": "The risk or severity of adverse effects can be increased when Fluorometholone is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Difluocortolone"
                    },
                    {
                        "drugbank-id": "DB00108",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Natalizumab"
                    },
                    {
                        "drugbank-id": "DB00337",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01656",
                        "description": "Roflumilast may increase the immunosuppressive activities of Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06688",
                        "description": "The therapeutic efficacy of Sipuleucel T can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "The risk or severity of neutropenia can be increased when Mitoxantrone is combined with Clozapine"
                    },
                    {
                        "drugbank-id": "DB00012",
                        "description": "The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00016",
                        "description": "The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The risk or severity of Thrombosis can be increased when Peginesatide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09107",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The serum concentration of Mitoxantrone can be increased when it is combined with Cyclosporine"
                    },
                    {
                        "drugbank-id": "DB09039",
                        "description": "The metabolism of Eliglustat can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The metabolism of Ibrutinib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The metabolism of Cilostazol can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The metabolism of Colchicine can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The metabolism of Fentanyl can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The metabolism of Iloperidone can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01256",
                        "description": "The metabolism of Retapamulin can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB08895",
                        "description": "The metabolism of Tofacitinib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The metabolism of Vardenafil can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "The metabolism of Eszopiclone can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01198",
                        "description": "The metabolism of Zopiclone can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The metabolism of Lovastatin can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The metabolism of Alfuzosin can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "The metabolism of Alprazolam can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The serum concentration of Warfarin can be increased when it is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The serum concentration of Acenocoumarol can be increased when it is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The serum concentration of R warfarin can be increased when it is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB08735",
                        "description": "The serum concentration of R S Warfarin alcohol can be increased when it is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB08736",
                        "description": "The serum concentration of S R Warfarin alcohol can be increased when it is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The serum concentration of S Warfarin can be increased when it is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "The serum concentration of Midazolam can be increased when it is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The serum concentration of Tacrolimus can be increased when it is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01076",
                        "description": "The metabolism of Atorvastatin can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01097",
                        "description": "The risk or severity of adverse effects can be increased when Mitoxantrone is combined with Leflunomide"
                    },
                    {
                        "drugbank-id": "DB00072",
                        "description": "Trastuzumab may increase the neutropenic activities of Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB08868",
                        "description": "Mitoxantrone may increase the immunosuppressive activities of Fingolimod"
                    },
                    {
                        "drugbank-id": "DB00511",
                        "description": "Acetyldigitoxin may decrease the cardiotoxic activities of Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01078",
                        "description": "Deslanoside may decrease the cardiotoxic activities of Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01092",
                        "description": "Ouabain may decrease the cardiotoxic activities of Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12843",
                        "description": "Oleandrin may decrease the cardiotoxic activities of Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13240",
                        "description": "Cymarin may decrease the cardiotoxic activities of Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13307",
                        "description": "Proscillaridin may decrease the cardiotoxic activities of Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13467",
                        "description": "Lanatoside C may decrease the cardiotoxic activities of Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13537",
                        "description": "Gitoformate may decrease the cardiotoxic activities of Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13756",
                        "description": "Peruvoside may decrease the cardiotoxic activities of Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "Digoxin may decrease the cardiotoxic activities of Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "Metildigoxin may decrease the cardiotoxic activities of Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "Acetyldigoxin may decrease the cardiotoxic activities of Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01217",
                        "description": "The risk or severity of cardiotoxicity can be increased when Mitoxantrone is combined with Anastrozole"
                    },
                    {
                        "drugbank-id": "DB06013",
                        "description": "The risk or severity of cardiotoxicity can be increased when Mitoxantrone is combined with Aldoxorubicin"
                    },
                    {
                        "drugbank-id": "DB06171",
                        "description": "The risk or severity of cardiotoxicity can be increased when Mitoxantrone is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB13809",
                        "description": "The risk or severity of cardiotoxicity can be increased when Mitoxantrone is combined with Paclitaxel poliglumex"
                    },
                    {
                        "drugbank-id": "DB06366",
                        "description": "The risk or severity of cardiotoxicity can be increased when Mitoxantrone is combined with Pertuzumab"
                    },
                    {
                        "drugbank-id": "DB04914",
                        "description": "The therapeutic efficacy of G17DT can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB05144",
                        "description": "The therapeutic efficacy of PEV3A can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB05325",
                        "description": "The therapeutic efficacy of INGN 225 can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB05374",
                        "description": "The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB05440",
                        "description": "The therapeutic efficacy of SRP 299 can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB05942",
                        "description": "The therapeutic efficacy of GI 5005 can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06400",
                        "description": "The therapeutic efficacy of Vitespen can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06584",
                        "description": "The therapeutic efficacy of TG4010 can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09057",
                        "description": "The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB10062",
                        "description": "The therapeutic efficacy of Rabies virus inactivated antigen B can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB10076",
                        "description": "The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB10276",
                        "description": "The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB10283",
                        "description": "The therapeutic efficacy of Rabies virus inactivated antigen A can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB10342",
                        "description": "The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB10583",
                        "description": "The therapeutic efficacy of Clostridium tetani toxoid antigen formaldehyde inactivated can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB10584",
                        "description": "The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen formaldehyde inactivated can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB10600",
                        "description": "The therapeutic efficacy of Influenza A virus A California 7 2009 X 181 H1N1 antigen propiolactone inactivated can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB10769",
                        "description": "The therapeutic efficacy of Japanese encephalitis virus strain sa 14 14 2 antigen formaldehyde inactivated can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB10794",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 antigen formaldehyde inactivated can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB10803",
                        "description": "The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB10989",
                        "description": "The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB10990",
                        "description": "The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11038",
                        "description": "The therapeutic efficacy of Influenza A virus A Brisbane 59 2007 H1N1 hemagglutinin antigen propiolactone inactivated can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11040",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 hemagglutinin antigen propiolactone inactivated can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11041",
                        "description": "The therapeutic efficacy of Influenza A virus A California 7 2009 X 181 H1N1 hemagglutinin antigen propiolactone inactivated can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11044",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 antigen propiolactone inactivated can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11603",
                        "description": "The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11627",
                        "description": "The therapeutic efficacy of Hepatitis B Vaccine Recombinant can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12568",
                        "description": "The therapeutic efficacy of Tecemotide can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB14022",
                        "description": "The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB14384",
                        "description": "The therapeutic efficacy of Influenza A virus A Victoria 210 2009 X 187 H3N2 hemagglutinin antigen formaldehyde inactivated can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB14385",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 hemagglutinin antigen formaldehyde inactivated can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB14394",
                        "description": "The therapeutic efficacy of Influenza A virus A California 7 2009 H1N1 live attenuated antigen can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB14445",
                        "description": "The therapeutic efficacy of Influenza A virus A Victoria 210 2009 X 187 H3N2 antigen formaldehyde inactivated can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB14449",
                        "description": "The therapeutic efficacy of Influenza A virus A Perth 16 2009 H3N2 live attenuated antigen can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB14619",
                        "description": "The therapeutic efficacy of Influenza A virus A Uruguay 716 2007 H3N2 antigen propiolactone inactivated can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB14620",
                        "description": "The therapeutic efficacy of Influenza A virus A Brisbane 59 2007 H1N1 antigen propiolactone inactivated can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB14711",
                        "description": "The therapeutic efficacy of Smallpox Vaccinia Vaccine Live can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB15274",
                        "description": "The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB15461",
                        "description": "The therapeutic efficacy of Yersinia pestis 195 p antigen formaldehyde inactivated can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13924",
                        "description": "The therapeutic efficacy of Varicella Zoster Vaccine Recombinant can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB15483",
                        "description": "The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB15595",
                        "description": "The therapeutic efficacy of Ebola Zaire vaccine live attenuated can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB15654",
                        "description": "The therapeutic efficacy of Moderna COVID 19 Vaccine can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00054",
                        "description": "The risk or severity of bleeding can be increased when Abciximab is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00063",
                        "description": "The risk or severity of bleeding can be increased when Eptifibatide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00261",
                        "description": "The risk or severity of bleeding can be increased when Anagrelide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00775",
                        "description": "The risk or severity of bleeding can be increased when Tirofiban is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "The risk or severity of bleeding can be increased when Pentoxifylline is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01088",
                        "description": "The risk or severity of bleeding can be increased when Iloprost is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01207",
                        "description": "The risk or severity of bleeding can be increased when Ridogrel is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "The risk or severity of bleeding can be increased when Epoprostenol is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB02709",
                        "description": "The risk or severity of bleeding can be increased when Resveratrol is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB04932",
                        "description": "The risk or severity of bleeding can be increased when Defibrotide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB05229",
                        "description": "The risk or severity of bleeding can be increased when Beraprost is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB05266",
                        "description": "The risk or severity of bleeding can be increased when Ibudilast is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB05767",
                        "description": "The risk or severity of bleeding can be increased when Andrographolide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06081",
                        "description": "The risk or severity of bleeding can be increased when Caplacizumab is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06209",
                        "description": "The risk or severity of bleeding can be increased when Prasugrel is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06441",
                        "description": "The risk or severity of bleeding can be increased when Cangrelor is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB08814",
                        "description": "The risk or severity of bleeding can be increased when Triflusal is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB08887",
                        "description": "The risk or severity of bleeding can be increased when Icosapent ethyl is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09283",
                        "description": "The risk or severity of bleeding can be increased when Trapidil is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12163",
                        "description": "The risk or severity of bleeding can be increased when Sarpogrelate is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12321",
                        "description": "The risk or severity of bleeding can be increased when Ifetroban is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "The risk or severity of bleeding can be increased when Nitroaspirin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "The risk or severity of bleeding can be increased when Ketanserin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "The risk or severity of bleeding can be increased when Indobufen is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12749",
                        "description": "The risk or severity of bleeding can be increased when Butylphthalide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12771",
                        "description": "The risk or severity of bleeding can be increased when Hydroxytyrosol is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13036",
                        "description": "The risk or severity of bleeding can be increased when Ramatroban is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13327",
                        "description": "The risk or severity of bleeding can be increased when Picotamide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13367",
                        "description": "The risk or severity of bleeding can be increased when Cloricromen is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "The risk or severity of bleeding can be increased when Linsidomine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13510",
                        "description": "The risk or severity of bleeding can be increased when Buflomedil is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13929",
                        "description": "The risk or severity of bleeding can be increased when Relcovaptan is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01138",
                        "description": "The risk or severity of bleeding can be increased when Sulfinpyrazone is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "The risk or severity of bleeding can be increased when Nimesulide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "The risk or severity of bleeding can be increased when Tranilast is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "The risk or severity of bleeding can be increased when Naftopidil is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00758",
                        "description": "The risk or severity of bleeding can be increased when Clopidogrel is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB04905",
                        "description": "The risk or severity of bleeding can be increased when Tesmilifene is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB08816",
                        "description": "The risk or severity of bleeding can be increased when Ticagrelor is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11988",
                        "description": "Ocrelizumab may increase the immunosuppressive activities of Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13200",
                        "description": "Mitoxantrone may increase the myelosuppressive activities of Lipegfilgrastim"
                    },
                    {
                        "drugbank-id": "DB10317",
                        "description": "The risk or severity of infection can be increased when Rubella virus vaccine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB10318",
                        "description": "The risk or severity of infection can be increased when Varicella Zoster Vaccine Live attenuated is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB10343",
                        "description": "The risk or severity of infection can be increased when Bacillus calmette guerin substrain tice live antigen is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB10804",
                        "description": "The risk or severity of infection can be increased when Bacillus calmette guerin substrain connaught live antigen is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB10805",
                        "description": "The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11003",
                        "description": "The risk or severity of infection can be increased when Anthrax vaccine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11050",
                        "description": "The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12386",
                        "description": "The risk or severity of infection can be increased when Bacillus calmette guerin substrain danish 1331 live antigen is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12768",
                        "description": "The risk or severity of infection can be increased when BCG vaccine is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB14409",
                        "description": "The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl 68578 antigen is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB14443",
                        "description": "The risk or severity of infection can be increased when Vibrio cholerae CVD 103 HgR strain live antigen is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB14685",
                        "description": "The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01051",
                        "description": "Novobiocin may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01094",
                        "description": "Hesperetin may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "Rabeprazole may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01685",
                        "description": "Topiroxostat may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB02115",
                        "description": "Daidzin may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "Fusidic acid may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB03467",
                        "description": "Naringenin may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06210",
                        "description": "Eltrombopag may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "Safinamide may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09061",
                        "description": "Cannabidiol may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12010",
                        "description": "Fostamatinib may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "Gilteritinib may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "Medical Cannabis may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14011",
                        "description": "Nabiximols may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12500",
                        "description": "Fedratinib may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "Istradefylline may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00201",
                        "description": "Caffeine may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00470",
                        "description": "Dronabinol may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12941",
                        "description": "Darolutamide may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08916",
                        "description": "Afatinib may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00175",
                        "description": "Pravastatin may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00213",
                        "description": "Pantoprazole may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "Nelfinavir may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00255",
                        "description": "Diethylstilbestrol may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00317",
                        "description": "Gefitinib may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "Omeprazole may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "Progesterone may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00448",
                        "description": "Lansoprazole may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "Ritonavir may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "Estradiol may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "Buprenorphine may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00966",
                        "description": "Telmisartan may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01645",
                        "description": "Genistein may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04216",
                        "description": "Quercetin may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04348",
                        "description": "Taurocholic acid may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB04881",
                        "description": "Elacridar may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05928",
                        "description": "Dovitinib may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06290",
                        "description": "Simeprevir may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08828",
                        "description": "Vismodegib may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09065",
                        "description": "Cobicistat may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09102",
                        "description": "Daclatasvir may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "Dasabuvir may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09291",
                        "description": "Rolapitant may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09297",
                        "description": "Paritaprevir may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11613",
                        "description": "Velpatasvir may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "Glasdegib may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11995",
                        "description": "Avatrombopag may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12026",
                        "description": "Voxilaprevir may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12070",
                        "description": "Letermovir may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12332",
                        "description": "Rucaparib may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13878",
                        "description": "Pibrentasvir may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13879",
                        "description": "Glecaprevir may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "Estradiol acetate may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13953",
                        "description": "Estradiol benzoate may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "Estradiol cypionate may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "Estradiol dienanthate may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "Estradiol valerate may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "Saquinavir may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB08864",
                        "description": "Rilpivirine may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14840",
                        "description": "Ripretinib may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11796",
                        "description": "Fostemsavir may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB15822",
                        "description": "Pralsetinib may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00655",
                        "description": "Estrone may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "Isavuconazole may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00845",
                        "description": "Clofazimine may decrease the excretion rate of Mitoxantrone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The metabolism of Aripiprazole can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The metabolism of Aripiprazole lauroxil can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00039",
                        "description": "The therapeutic efficacy of Palifermin can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "Venlafaxine may increase the excretion rate of Mitoxantrone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04540",
                        "description": "Cholesterol may increase the excretion rate of Mitoxantrone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "Apalutamide may increase the excretion rate of Mitoxantrone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "The metabolism of Lorazepam can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The metabolism of Phentermine can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The metabolism of Ticlopidine can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The metabolism of Ziprasidone can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00426",
                        "description": "The metabolism of Famciclovir can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The metabolism of Prochlorperazine can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00567",
                        "description": "The metabolism of Cephalexin can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00717",
                        "description": "The metabolism of Norethisterone can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "The metabolism of Rosuvastatin can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The metabolism of St John s Wort can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "The metabolism of Drospirenone can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01411",
                        "description": "The metabolism of Pranlukast can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01431",
                        "description": "The metabolism of Allylestrenol can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The metabolism of Zuclopenthixol can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06201",
                        "description": "The metabolism of Rufinamide can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "The metabolism of Lacosamide can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "The metabolism of Tasimelteon can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11094",
                        "description": "The metabolism of Vitamin D can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11273",
                        "description": "The metabolism of Dihydroergocornine can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The metabolism of Ribociclib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12515",
                        "description": "The metabolism of 9 aminocamptothecin can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12952",
                        "description": "The metabolism of Methylprednisone can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13345",
                        "description": "The metabolism of Dihydroergocristine can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13385",
                        "description": "The metabolism of Dihydroergocryptine can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00549",
                        "description": "The metabolism of Zafirlukast can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB15444",
                        "description": "The metabolism of Elexacaftor can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The metabolism of Azithromycin can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "The metabolism of Metoprolol can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The metabolism of Duloxetine can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The metabolism of Chlorpromazine can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00518",
                        "description": "The metabolism of Albendazole can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "The metabolism of Doxazosin can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "The metabolism of Fenofibrate can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The metabolism of Atazanavir can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06717",
                        "description": "The metabolism of Fosaprepitant can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB08882",
                        "description": "The metabolism of Linagliptin can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The metabolism of Vorapaxar can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "The metabolism of Suvorexant can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The metabolism of Netupitant can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09079",
                        "description": "The metabolism of Nintedanib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09299",
                        "description": "The metabolism of Tenofovir alafenamide can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11952",
                        "description": "The metabolism of Duvelisib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12887",
                        "description": "The metabolism of Tazemetostat can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB14126",
                        "description": "The metabolism of Tenofovir can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "The metabolism of Lefamulin can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "The metabolism of Methysergide can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The metabolism of Meperidine can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The metabolism of Ebastine can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The metabolism of Terfenadine can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The metabolism of Cisapride can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Bortezomib"
                    },
                    {
                        "drugbank-id": "DB00309",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Vindesine"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Vinorelbine"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Teniposide"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Cyclophosphamide"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Methotrexate"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Vinblastine"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Irinotecan"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Etoposide"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Ifosfamide"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The metabolism of Docetaxel can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The metabolism of Sunitinib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "The metabolism of Thiotepa can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB04845",
                        "description": "The metabolism of Ixabepilone can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The metabolism of Nilotinib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The metabolism of Trabectedin can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The metabolism of Trastuzumab emtansine can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The metabolism of Panobinostat can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The metabolism of Cabazitaxel can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "The metabolism of Ruxolitinib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The metabolism of Ponatinib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09054",
                        "description": "The metabolism of Idelalisib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The metabolism of Palbociclib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "The metabolism of Olaparib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "The metabolism of Baricitinib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Dasatinib"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Vandetanib"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Dacomitinib"
                    },
                    {
                        "drugbank-id": "DB12267",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Brigatinib"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Pimozide"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Amiodarone"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Dronedarone"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The metabolism of Dofetilide can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The metabolism of Theophylline can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The metabolism of Phenprocoumon can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01008",
                        "description": "The metabolism of Busulfan can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01223",
                        "description": "The metabolism of Aminophylline can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The metabolism of Fosphenytoin can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The metabolism of Tianeptine can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Vemurafenib"
                    },
                    {
                        "drugbank-id": "DB05239",
                        "description": "The metabolism of Cobimetinib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The metabolism of Ceritinib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09330",
                        "description": "The metabolism of Osimertinib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12015",
                        "description": "The metabolism of Alpelisib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The metabolism of Carbamazepine can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The metabolism of Sirolimus can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The metabolism of Quinidine can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The metabolism of Paclitaxel can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The metabolism of Digitoxin can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The metabolism of Everolimus can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The metabolism of Temsirolimus can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Erlotinib"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Regorafenib"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Dabrafenib"
                    },
                    {
                        "drugbank-id": "DB11363",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Alectinib"
                    },
                    {
                        "drugbank-id": "DB11581",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Venetoclax"
                    },
                    {
                        "drugbank-id": "DB12001",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Abemaciclib"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Enasidenib"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The metabolism of Tamoxifen can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Vincristine"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The metabolism of Mitoxantrone can be decreased when combined with Doxorubicin"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The metabolism of Pazopanib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The metabolism of Bosutinib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB08870",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12371",
                        "description": "The metabolism of Siponimod can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The metabolism of Astemizole can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB08827",
                        "description": "The metabolism of Lomitapide can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11641",
                        "description": "The metabolism of Vinflunine can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11703",
                        "description": "The metabolism of Acalabrutinib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB15035",
                        "description": "The metabolism of Zanubrutinib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The metabolism of Cabergoline can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06595",
                        "description": "The metabolism of Midostaurin can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06626",
                        "description": "The metabolism of Axitinib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The metabolism of Crizotinib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09143",
                        "description": "The metabolism of Sonidegib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09570",
                        "description": "The metabolism of Ixazomib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11828",
                        "description": "The metabolism of Neratinib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The metabolism of Erdafitinib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12483",
                        "description": "The metabolism of Copanlisib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12978",
                        "description": "The metabolism of Pexidartinib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The metabolism of Ivosidenib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The metabolism of Clonidine can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The metabolism of Romidepsin can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "The metabolism of Tolvaptan can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The metabolism of Nortriptyline can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "The metabolism of Ergotamine can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "The metabolism of Conivaptan can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01128",
                        "description": "The metabolism of Bicalutamide can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The metabolism of Levacetylmethadol can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The metabolism of Clomipramine can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00228",
                        "description": "The metabolism of Enflurane can be increased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The metabolism of Isoflurane can be increased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06728",
                        "description": "The metabolism of Aniline can be increased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The metabolism of Trimethadione can be increased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "The metabolism of Chlorzoxazone can be increased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "The metabolism of Ethanol can be increased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00949",
                        "description": "The metabolism of Felbamate can be increased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01028",
                        "description": "The metabolism of Methoxyflurane can be increased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "The metabolism of Halothane can be increased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The metabolism of Sevoflurane can be increased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The metabolism of Nilvadipine can be increased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06119",
                        "description": "The metabolism of Cenobamate can be increased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The metabolism of Phenytoin can be increased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The metabolism of Carvedilol can be increased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06770",
                        "description": "The metabolism of Benzyl alcohol can be increased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The metabolism of Ethosuximide can be increased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11689",
                        "description": "The metabolism of Selumetinib can be increased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "The metabolism of Primidone can be increased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "The metabolism of Phenobarbital can be increased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00001",
                        "description": "The risk or severity of bleeding can be increased when Lepirudin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00006",
                        "description": "The risk or severity of bleeding can be increased when Bivalirudin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00009",
                        "description": "The risk or severity of bleeding can be increased when Alteplase is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00013",
                        "description": "The risk or severity of bleeding can be increased when Urokinase is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00015",
                        "description": "The risk or severity of bleeding can be increased when Reteplase is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00029",
                        "description": "The risk or severity of bleeding can be increased when Anistreplase is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00031",
                        "description": "The risk or severity of bleeding can be increased when Tenecteplase is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00055",
                        "description": "The risk or severity of bleeding can be increased when Drotrecogin alfa is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00086",
                        "description": "The risk or severity of bleeding can be increased when Streptokinase is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The risk or severity of bleeding can be increased when Dicoumarol is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00407",
                        "description": "The risk or severity of bleeding can be increased when Ardeparin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The risk or severity of bleeding can be increased when Phenindione is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00569",
                        "description": "The risk or severity of bleeding can be increased when Fondaparinux is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00686",
                        "description": "The risk or severity of bleeding can be increased when Pentosan polysulfate is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01109",
                        "description": "The risk or severity of bleeding can be increased when Heparin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01225",
                        "description": "The risk or severity of bleeding can be increased when Enoxaparin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The risk or severity of bleeding can be increased when Coumarin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB04898",
                        "description": "The risk or severity of bleeding can be increased when Ximelagatran is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB04925",
                        "description": "The risk or severity of bleeding can be increased when Desmoteplase is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB05099",
                        "description": "The risk or severity of bleeding can be increased when Ancrod is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB05254",
                        "description": "The risk or severity of bleeding can be increased when Fibrinolysin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06271",
                        "description": "The risk or severity of bleeding can be increased when Sulodexide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06294",
                        "description": "The risk or severity of bleeding can be increased when Semuloparin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06406",
                        "description": "The risk or severity of bleeding can be increased when Idraparinux is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06543",
                        "description": "The risk or severity of bleeding can be increased when Astaxanthin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06635",
                        "description": "The risk or severity of bleeding can be increased when Otamixaban is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06679",
                        "description": "The risk or severity of bleeding can be increased when Amediplase is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06754",
                        "description": "The risk or severity of bleeding can be increased when Danaparoid is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06779",
                        "description": "The risk or severity of bleeding can be increased when Dalteparin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06822",
                        "description": "The risk or severity of bleeding can be increased when Tinzaparin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "The risk or severity of bleeding can be increased when Ferulic acid is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB08813",
                        "description": "The risk or severity of bleeding can be increased when Nadroparin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB08994",
                        "description": "The risk or severity of bleeding can be increased when Ditazole is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09125",
                        "description": "The risk or severity of bleeding can be increased when Potassium citrate is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09154",
                        "description": "The risk or severity of bleeding can be increased when Sodium citrate is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09255",
                        "description": "The risk or severity of bleeding can be increased when Dextran is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09258",
                        "description": "The risk or severity of bleeding can be increased when Bemiparin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09260",
                        "description": "The risk or severity of bleeding can be increased when Parnaparin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11095",
                        "description": "The risk or severity of bleeding can be increased when Desirudin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11154",
                        "description": "The risk or severity of bleeding can be increased when Zinc citrate is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11166",
                        "description": "The risk or severity of bleeding can be increased when Antithrombin Alfa is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11312",
                        "description": "The risk or severity of bleeding can be increased when Protein C is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11598",
                        "description": "The risk or severity of bleeding can be increased when Antithrombin III human is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11984",
                        "description": "The risk or severity of bleeding can be increased when Letaxaban is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12289",
                        "description": "The risk or severity of bleeding can be increased when Darexaban is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12598",
                        "description": "The risk or severity of bleeding can be increased when Nafamostat is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12726",
                        "description": "The risk or severity of bleeding can be increased when Monteplase is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12831",
                        "description": "The risk or severity of bleeding can be increased when Gabexate is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13149",
                        "description": "The risk or severity of bleeding can be increased when Protein S human is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13199",
                        "description": "The risk or severity of bleeding can be increased when Brinase is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The risk or severity of bleeding can be increased when Tioclomarol is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13616",
                        "description": "The risk or severity of bleeding can be increased when Melagatran is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13646",
                        "description": "The risk or severity of bleeding can be increased when Saruplase is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "The risk or severity of bleeding can be increased when Tocopherylquinone is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB14598",
                        "description": "The risk or severity of bleeding can be increased when Edetate calcium disodium anhydrous is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB14726",
                        "description": "The risk or severity of bleeding can be increased when Dabigatran is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00278",
                        "description": "The risk or severity of bleeding can be increased when Argatroban is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "The risk or severity of bleeding can be increased when Acetylsalicylic acid is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00975",
                        "description": "The risk or severity of bleeding can be increased when Dipyridamole is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06605",
                        "description": "The risk or severity of bleeding can be increased when Apixaban is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "The risk or severity of bleeding can be increased when Dabigatran etexilate is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "The risk or severity of bleeding can be increased when Edoxaban is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB12364",
                        "description": "The risk or severity of bleeding can be increased when Betrixaban is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "The risk or severity of bleeding can be increased when Rivaroxaban is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The risk or severity of bleeding can be increased when Ethyl biscoumacetate is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The risk or severity of bleeding can be increased when Diphenadione is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The risk or severity of bleeding can be increased when 4 hydroxycoumarin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The risk or severity of bleeding can be increased when Fluindione is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The risk or severity of bleeding can be increased when Clorindione is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13124",
                        "description": "The risk or severity of bleeding can be increased when Troxerutin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00974",
                        "description": "The risk or severity of bleeding can be increased when Edetic acid is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09259",
                        "description": "The risk or severity of bleeding can be increased when Reviparin is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "The risk or severity of neutropenia and thrombocytopenia can be increased when Methyclothiazide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "The risk or severity of neutropenia and thrombocytopenia can be increased when Bendroflumethiazide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00562",
                        "description": "The risk or severity of neutropenia and thrombocytopenia can be increased when Benzthiazide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclothiazide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "The risk or severity of neutropenia and thrombocytopenia can be increased when Hydroflumethiazide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "The risk or severity of neutropenia and thrombocytopenia can be increased when Chlorothiazide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00999",
                        "description": "The risk or severity of neutropenia and thrombocytopenia can be increased when Hydrochlorothiazide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "The risk or severity of neutropenia and thrombocytopenia can be increased when Trichlormethiazide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "The risk or severity of neutropenia and thrombocytopenia can be increased when Polythiazide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13430",
                        "description": "The risk or severity of neutropenia and thrombocytopenia can be increased when Mebutizide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "The risk or severity of neutropenia and thrombocytopenia can be increased when Cyclopenthiazide is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09042",
                        "description": "The risk or severity of myelosuppression can be increased when Mitoxantrone is combined with Tedizolid phosphate"
                    },
                    {
                        "drugbank-id": "DB06480",
                        "description": "The metabolism of Prucalopride can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00115",
                        "description": "The therapeutic efficacy of Cyanocobalamin can be decreased when used in combination with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00437",
                        "description": "The risk or severity of adverse effects can be increased when Allopurinol is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "Acetaminophen may increase the hepatotoxic activities of Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "Mitoxantrone may increase the hepatotoxic activities of Propacetamol"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The metabolism of Entrectinib can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11732",
                        "description": "The serum concentration of Mitoxantrone can be increased when it is combined with Lasmiditan"
                    },
                    {
                        "drugbank-id": "DB14975",
                        "description": "The serum concentration of Voxelotor can be increased when it is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB09237",
                        "description": "The serum concentration of Levamlodipine can be increased when it is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11644",
                        "description": "The serum concentration of Mitoxantrone can be increased when it is combined with Tafamidis"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The metabolism of Tramadol can be decreased when combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The serum concentration of Magnesium can be decreased when it is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The serum concentration of Mitoxantrone can be increased when it is combined with Lopinavir"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The serum concentration of Haloperidol can be increased when it is combined with Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB11791",
                        "description": "The serum concentration of Mitoxantrone can be increased when it is combined with Capmatinib"
                    },
                    {
                        "drugbank-id": "DB12530",
                        "description": "The risk or severity of infection can be increased when Mitoxantrone is combined with Inebilizumab"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}